首页> 美国卫生研究院文献>International Journal of Nanomedicine >Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid micelles
【2h】

Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid micelles

机译:使用新型脱氧胆酸-O-羧甲基化壳聚糖-叶酸胶束的叶酸介导的紫杉醇靶向和细胞内递送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundA critical disadvantage for successful chemotherapy with paclitaxel (PTX) is its nontargeting nature to cancer cells. Folic acid has been employed as a targeting ligand of various anticancer agents to increase their cellular uptake within target cells since the folate receptor is overexpressed on the surface of such tumor cells. In this study, a novel biodegradable deoxycholic acid-O-carboxymethylated chitosan–folic acid conjugate (DOMC-FA) was used to form micelles for encapsulating the anticancer drug PTX.
机译:背景技术紫杉醇(PTX)成功化疗的关键缺点是其对癌细胞的非靶向性质。叶酸已被用作各种抗癌剂的靶向配体,以增加其在靶细胞内的细胞摄取,因为叶酸受体在此类肿瘤细胞的表面上过表达。在这项研究中,一种新型的可生物降解的脱氧胆酸-O-羧甲基化壳聚糖-叶酸共轭物(DOMC-FA)被用来形成胶束以封装抗癌药PTX。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号